{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "CRM",
  "name": "Salesforce, Inc.",
  "url": "https://orbyd.app/dossiers/CRM/",
  "json_url": "https://orbyd.app/dossiers/CRM.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "De-rated Dow laggard with a dated agentic-AI revenue proof point: the $1.6B three-year VA agentic ELA (2026-07-24) drove a 7% session on 2026-07-27 while the stock still trades near 13.8x the FY27 non-GAAP EPS guide. The 2026-08-26 Q2 FY27 print is the binary — cRPO ran +14% Y/Y in Q1 and Morgan Stanley's $185 target sits below the market.",
  "invalidation_trigger": "A daily close below $180 surrenders the entire 2026-07-27 VA-contract advance and returns price beneath Morgan Stanley's $185 target (set 2026-07-21). Secondary: a 2026-08-26 Q2 FY27 print that trims rather than holds the $45.9–46.2B FY27 revenue guide, or shows cRPO growth below the +14% Y/Y Q1 pace.",
  "catalyst_date": "2026-08-26",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software",
    "ai-datacenter-infrastructure"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends January 31 — the Q2 FY27 print due 2026-08-26 covers the quarter ended 2026-07-31.",
    "Dow Jones Industrial Average component; index rebalancing and Dow-flow effects are a persistent presence in the tape.",
    "FY27 reported growth includes the Informatica acquisition, so headline revenue growth overstates the organic rate.",
    "Consensus target dispersion is unusually wide: $160 low to $475 high across 53 analysts as of 2026-08-07 (stockanalysis.com)."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg on offer is a de-rating reversal, not a growth story. Salesforce closed at $192.74 on 2026-08-07, 27.2% below its 52-week high of $264.88, against FY27 non-GAAP diluted EPS guidance of $14.06–$14.12 issued with the Q1 FY27 release on 2026-05-27 — roughly 13.8x forward earnings per stockanalysis.com's 2026-08-07 screen. What changed in July is that the agentic product line produced a single verifiable dollar figure: a $1.6B, three-year agentic enterprise license agreement from the U.S. Department of Veterans Affairs, announced 2026-07-24, which moved the stock 7% on 2026-07-27. The 2026-08-26 Q2 FY27 print, after the close, decides whether that is the start of a re-rating or a one-contract headline inside a decelerating seat-based franchise.\n\n**Life-cycle: MATURING.** The Agentforce narrative is fully distributed — it is why the stock carried a premium into 2025 and why Benzinga could run the headline \"Why is Salesforce the Worst-Performing Dow Jones Stock?\" on 2026-07-25. Morgan Stanley's 2026-07-21 downgrade to Equal-Weight with the target cut from $287 to $185 is sell-side moving to neutral on a name it already owned the thesis on. Working operationally (cRPO +14% Y/Y in Q1 FY27), moderating in flow, with one fresh dated catalyst — the federal ELA — that has not yet been repeated.\n\n## Bull Case\n\n- **Q1 FY27 (reported 2026-05-27): revenue $11.13B, +13% Y/Y; cRPO $33.6B, +14% Y/Y; total RPO $67.9B, +11% Y/Y.** Bookings growth running ahead of reported revenue growth is the specific number the bear case has to break.\n- **FY27 revenue guidance raised to $45.9–$46.2B (+11% Y/Y) at the Q1 print**, with full-year non-GAAP operating margin guided to 34.3% and GAAP to 20.6%. A guide going up while the multiple goes down is the entire arithmetic of the setup.\n- **Agentforce and Data 360 combined ARR of $3.4B, with Agentforce ARR up more than 200% Y/Y** as disclosed at the Q1 FY27 release. The base is small against $42.83B trailing revenue (stockanalysis.com, 2026-08-07), but it is a disclosed line rather than a slide.\n- **The VA award, announced 2026-07-24, is $1.6B over three years covering services to more than 17 million veterans** — a federal agentic deployment at contract scale, in the same week Oracle's $7B defense deal was reported. Government agentic buying is showing up as awarded dollars.\n- **Valuation gap is wide and dispersed:** consensus target $241.72 across 53 analysts, low $160, high $475 (stockanalysis.com, 2026-08-07). Trailing P/E 22.37 versus forward 13.84 on EPS of $8.61.\n\n## Bear Case\n\n- **Morgan Stanley's Adam Wood cut CRM to Equal-Weight on 2026-07-21 and took the target from $287 to $185** — a 35% reduction that lands *below* the 2026-08-07 close. The most recent full re-underwrite by a major desk sits under the market price.\n- **The disruption trade is live and priced elsewhere in the group.** UiPath fell 13% on 2026-07-22 on OpenAI's \"Presence\" enterprise platform launch. Seat-based application software is the direct target of that product category, and CRM is the largest seat-based franchise in the index.\n- **Slack, acquired for roughly $28B, now faces a purpose-built competitor from Jack Dorsey** (reported 2026-07-22). No revenue impact is measurable yet; the risk is to the multiple, not the quarter.\n- **FY27 growth is partly inorganic.** Salesforce attributed Q1 FY27 growth to Agentforce, Data 360, Slack *and the Informatica acquisition*. Organic growth is the number to isolate on 2026-08-26.\n- **FY2026 revenue was $41.53B, +9.58% over FY2025's $37.90B** — the compounding rate is single-digit before acquisitions, which is why the de-rating happened in the first place.\n- Steve Eisman's 2026-07-15 remark that AI firms have \"no moats\" is a sentiment marker, not evidence, but it dates the macro overhang the group is trading under.\n\n## Setup & Price Structure\n\nClose $192.74 (2026-08-07), RSI(14) 61.8, three-month return +6.3%, 27.2% below the 52-week high of $264.88. Price sits between two named levels: Morgan Stanley's $185 target underneath and the $211 resistance Benzinga flagged on 2026-07-28 after the stock \"jumped past short-term moving averages\" on the VA news. Neither has been resolved.\n\nPositioning observables, stated without a verdict on them:\n\n- The 2026-07-27 advance was 7% in one session on a contract announcement — a gap driven by news, which leaves an unfilled zone beneath price.\n- Retail-attention coverage clustered hard in a two-week window: three \"Why is Salesforce stock surging/falling\" explainers (2026-07-21, 07-27, 07-28) plus two twenty-year-return retrospectives (2026-07-22, 2026-08-04) and a \"Salesforce Stock Is Gaining Monday: What's Going On?\" on 2026-08-03. The 20-year-hypothetical-return format is an attention genre, and it appeared twice in thirteen days.\n- CRM appeared in Benzinga's IT whale-activity options scans on 2026-07-24 and 2026-08-06.\n- Market capitalization was quoted at $138.82B by Benzinga on 2026-07-22 and $157.85B by stockanalysis.com on 2026-08-07 (different sources, different dates — the direction is the point).\n- Earnings land 2026-08-26, eighteen calendar days from the price basis. No insider transactions appear in the filing record reviewed for this note.\n- The name is a Dow Jones Industrial Average component and was the index's worst performer as of 2026-07-25, meaning index-level rebalancing flow is a persistent presence in the tape.\n\nThe structure is a stock that has rallied into a print off a downgrade low, is not extended against its own 52-week range, and carries a positive but not stretched momentum reading.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-26 (confirmed, after market close):** Q2 FY27 earnings release and 2:00pm PT / 5:00pm ET call. Guidance issued 2026-05-27 was $11.27–$11.35B for the quarter, +10–11% Y/Y.\n- **2026-08-26:** FY27 full-year guide reset in the same release — whether $45.9–$46.2B and non-GAAP EPS $14.06–$14.12 hold, rise, or come down.\n- **2026-08-26:** cRPO print. Q1 FY27 was $33.6B, +14% Y/Y. This is the single line the LLM-disruption thesis has to show cracking.\n- **~2026-08-27 to 2026-09-04 (est.):** post-print analyst target revisions. Morgan Stanley's $185 (2026-07-21) is the marker to watch for restoration or confirmation.\n- No other company-controlled dated event falls inside the window. Dreamforce is an autumn event and its 2026 date is outside the next 30 days.\n\n## What Would Change Our Mind\n\nThe structure that has to hold is the July contract advance. A daily close below $180 gives back the entire move that followed the 2026-07-24 VA announcement and returns the stock beneath the $185 target Morgan Stanley set on 2026-07-21 — at which point the market has voted that a $1.6B three-year federal ELA did not change the earnings path, and the de-rating case is the operative one.\n\nThe fundamental break is separable and lands on one date. If the 2026-08-26 release shows cRPO growth decelerating materially from the +14% Y/Y posted in Q1 FY27, or the FY27 revenue guide of $45.9–$46.2B is trimmed rather than held or raised, the \"cheap and compounding\" frame stops describing the company. Equally: a beat-and-raise on 2026-08-26 that is followed by a lower close inside the following week would say the multiple is the constraint and no operating result fixes it in this tape.\n\nOn the upside, a weekly close above $211 clears the resistance shelf Benzinga identified on 2026-07-28 and would mark the first structural break in the twelve-month downtrend.\n\nA second federal or large-enterprise agentic ELA disclosed at similar scale to the VA award would move the read from MATURING toward a re-accelerating one; a full quarter passing with no repeat would confirm the single-contract interpretation.\n\n## Correlation Notes\n\n- **Seat-based application software as a factor.** The UiPath -13% session on 2026-07-22, triggered by OpenAI's \"Presence\" enterprise launch, is the cleanest proxy for what a fresh LLM-native product announcement does to this complex. CRM has the largest seat exposure in it.\n- **Federal AI contracting.** Oracle's $7B defense award and the CRM $1.6B VA award landed in the same reporting week (week of 2026-07-20). Government agentic budgets are a shared driver, and shared exposure to appropriations risk.\n- **Dow versus Nasdaq divergence.** The Nasdaq 100 entered correction on 2026-07-28 during a chip rout while CRM was rallying on its own contract news. The July move was idiosyncratic, which cuts both ways — it does not have index beta supporting it.\n- **Data/integration adjacency.** Informatica now sits inside the reported numbers, linking CRM's growth line to enterprise data-management demand rather than pure CRM seats.\n- **Collaboration software.** Slack's competitive position is now a named narrative (Dorsey, 2026-07-22) that will trade on product headlines rather than on Salesforce's own disclosure cadence.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-08T07:32:57+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}